A Study of JNJ-73763989, Pegylated Interferon Alpha-2a and Nucleos(t)Ide Analogs in Participants With Chronic Hepatitis B Virus Infection
Clinical trial NCT05005507 · TERMINATED
Trial details
- NCT number
- NCT05005507
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-03
- Primary completion
- 2021-12-29
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.